News
He has boasted about the accuracy of subscription-based Grok artificial intelligence for analyzing medical images, but physicians and researchers say the model's ability to diagnose medical conditions is limited, and privacy experts have concerns.
The CRISPR therapy, HG202, was conceived using AI and machine learning and aims to treat individuals with neovascular age-related macular degeneration.
Last week, the wearables company announced it opened an investigation into apparent manipulation in trading its common shares following a 1-for-15 reverse stock split.
MedAware's AI-enabled platform allows pharmacists and clinical care personnel to intervene with medication dosages and therapy changes before potential harm occurs.
The funds will be used to scale partnerships with health plans, employers and community-based public health agencies across the country.
The acquisition of data company Sparta Science will allow Oura to expand its data analytics capabilities and its B2B offerings.
Physicians will have the ability to compare medication prices in real-time and prescribe using eNavvi's platform.
The investigation follows shareholder approval of a 1-for-15 reverse stock that took effect earlier this week.
The partnership will facilitate same-day screening for people with Alzheimer's and other dementias.
ProPhet's aim is to bring down the time and cost of finding molecules for new drug targets.